Drug intelligence / Profile preview

Huangkui Lianchang decoction

Development stage
Unknown
Lead developer
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Rectal, Oral
01

Overview

Huangkui Lianchang decoction (HLD) is a traditional Chinese medicine (TCM) herbal formula primarily utilized for the treatment of ulcerative colitis (UC). Its primary active component is derived from *Abelmoschus manihot* (L.) Medicus, commonly known as Huangshukui. The formula is frequently administered as a retention enema (HKE) to provide localized therapeutic effects for mild-to-moderate active distal or left-sided colonic UC. Mechanistically, HLD exerts potent anti-inflammatory effects by inhibiting the TLR4/MyD88/NF-κB signaling pathway, which leads to the downregulation of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6). Additionally, it has been shown to modulate autophagy and improve intestinal barrier function. Clinical research, including multicenter randomized controlled trials, has demonstrated that HLD can achieve clinical remission and mucosal healing rates comparable to standard treatments like mesalazine.

Other names
Huangkui Lianchang decoction enema solutionHKE enema
02

Targets

MYD88 (Myeloid differentiation primary response protein MyD88)NF-κBTLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on Huangkui Lianchang decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huangkui Lianchang decoction.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call